T/GDPMAA 0001-2020 Active Group standards

T/GDPMAA 0001-2020 Prenatal genetic diagnosis copy number variation and homozygous region data analysis interpretation and reporting specifications

Publish Date: 2020-05-15 Implement Date: 2020-05-16 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/GDPMAA 0001-2020

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: Medicine, health, and labor protection

ICS Name: Laboratory medicine

Publish Date: 2020-05-15

Implement Date: 2020-05-16

Scope

Scope: This standard applies to hospitals, third-party medical testing institutions, or university diagnostic laboratories with qualifications for clinical prenatal genetic diagnosis, which use chromosomal microarray analysis (CMA) or next-generation sequencing-based genome copy number variation sequencing technology (CNV-seq) for data analysis, result interpretation, and report issuance of CNV and ROH. Main technical content: This standard specifies the data analysis process, informed consent forms, and report content and requirements for copy number variations (CNV) and genome homozygous regions (ROH) in prenatal genetic diagnosis.